Mesoblast (MESO) Liabilities and Shareholders Equity (2015 - 2026)
Mesoblast (MESO) reported Liabilities and Shareholders Equity of $773.08 million for the quarter ended Jun 30, 2026, down 1.5% from $784.68 million a year earlier.
Powered by 
Analysis
Mesoblast (MESO) Liabilities and Shareholders Equity (2015 - 2026) Analysis & Trends
Dating back to the quarter ended Jun 30, 2015, Mesoblast's Liabilities and Shareholders Equity record includes 39 quarters.
- Liabilities and Shareholders Equity has a five-year compound annual growth rate of 0.8% (years ended Jun 2021 to Jun 2026).
- By year, Liabilities and Shareholders Equity came in at $784.68 million in the year ended Jun 30, 2025 (+17.3%), $669.15 million in the year ended Jun 30, 2024 (unchanged), $669.42 million in the year ended Jun 30, 2023 (+1.1%) and $662.14 million in the year ended Jun 30, 2022 (-11.1%).
- The figure for the quarter ended Jun 30, 2026 ranks as the lowest quarterly Liabilities and Shareholders Equity since the quarter ended Dec 31, 2024.
- Year over year, Liabilities and Shareholders Equity gained in two of the last four quarters, with growth averaging 8.2%.
- The high point for year-over-year Liabilities and Shareholders Equity in five years was the quarter ended Dec 31, 2025 (growth of 19.7%); the low point was the quarter ended Jun 30, 2022 (a decline of 11.1%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Mesoblast | 1.90 Bn | 1.46 Bn | - | 773.08 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 773.08 Mn |
| Dec 31, 2025 | 782.31 Mn |
| Jun 30, 2025 | 784.68 Mn |
| Dec 31, 2024 | 653.32 Mn |
| Jun 30, 2024 | 669.15 Mn |
| Dec 31, 2023 | 670.29 Mn |
| Jun 30, 2023 | 669.42 Mn |
| Mar 31, 2023 | 650.44 Mn |
| Dec 31, 2022 | 668.06 Mn |
| Sep 30, 2022 | 684.50 Mn |
| Jun 30, 2022 | 662.14 Mn |
| Mar 31, 2022 | 681.69 Mn |
| Dec 31, 2021 | 704.44 Mn |
| Sep 30, 2021 | 721.82 Mn |
| Jun 30, 2021 | 744.72 Mn |
| Mar 31, 2021 | 766.13 Mn |
| Dec 31, 2020 | 687.31 Mn |
| Sep 30, 2020 | 712.57 Mn |
| Jun 30, 2020 | 733.60 Mn |
| Mar 31, 2020 | 665.79 Mn |
API Access
Mesoblast Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=MESO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "MESO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=MESO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();